Friday, August 5, 2022
OANDP-L
  • Login
No Result
View All Result
The O&P EDGE
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
  • PECOS
  • Magazine
    • Subscription
    • Current Issue
    • Issue Archive
    • News Archive
    • Product & Service Directory
    • Advertising Information
  • O&P Jobs
    • Find a Job
    • Post a Job
  • EDGE Advantage
  • O&P Facilities
  • Resources
    • Product & Service Directory
    • Calendar
    • Contact
    • About Us
    • O&P Library
    • The Guide
    • Custom Publications
    • Advertising Information
    • EDGE Direct
    • Amplitude Media Group
No Result
View All Result
The O&P EDGE Magazine
No Result
View All Result
Home News

FDA Approval Received to Test Amputation-Pain-Blocking Technology

by The O&P EDGE
October 10, 2013
in News
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Neuros Medical, Willoughby, Ohio, announced that it has received an Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) allowing it to commence a clinical trial to evaluate the company’s patented Altiusâ„¢ System High Frequency Nerve Block technology for the management of intractable limb pain of individuals with amputations.

The prospective, randomized, controlled clinical trial will consist of 130 patients at 15 institutions in the United States to evaluate the safety and efficacy of Neuros Medical’s Altius System. Neuros recently announced the results of its long-term pilot study, which reported significant pain reduction. In addition, more than half of the subjects discontinued their pain medication use during the study.

“We look forward to executing the next steps in the pivotal study process with the eventual goal of receiving approval to market the Altius System to provide long-term pain relief to those suffering from chronic amputation pain,” said Jon J. Snyder, president and CEO of Neuros Medical.

Related posts:

  1. Pilot Study to Begin on Pain Innovation Device
  2. Neuros Medical Announces Pilot Study Results
  3. Amputee Pain-management System Receives FDA Designation
  4. Neuros Medical Reaches Milestones in Post-amputation Pain Study
Previous Post

IDEO Inventor Joins Hanger Clinic

Next Post

Ottobock Hosts 3rd T.O.D.D. Field Day

Next Post

Ottobock Hosts 3rd T.O.D.D. Field Day

  • VIEW CURRENT ISSUE
  • SUBSCRIBE FOR FREE

RECENT NEWS

News

NAAOP To Host Virtual Congressional Fly-in

by The O&P EDGE
July 27, 2022

The National Association for the Advancement of Orthotics and Prosthetics (NAAOP) is hosting the 2022 Virtual Congressional Fly-in on Thursday,...

Read more

Research Shows Function Improvements With Multiarticulating Hands

ROMP Hires

SPS Names New Sales Manager

Get unlimited access!

Join EDGE ADVANTAGE and unlock The O&P EDGE's vast library of archived content.
SUBSCRIBE TODAY

O&P JOBS

Central

CPO – Orthotics and Prosthetics – Full Time

Pacific

CPO

Central

Were Growing!

 

© 2021 The O&P EDGE

  • About
  • Advertise
  • Contact
  • EDGE Advantage
  • OANDP-L
  • Subscribe

CONTACT US

866-613-0257

[email protected]

201 E. 4th St
Loveland, CO 80537

The most important industry news and events delivered directly to your inbox every week.

No Result
View All Result
  • PECOS
  • MAGAZINE
    • SUBSCRIBE
    • CURRENT ISSUE
    • ISSUE ARCHIVE
    • NEWS ARCHIVE
    • PRODUCTS & SERVICES DIRECTORY
    • ADVERTISING INFORMATION
  • O&P JOBS
    • FIND A JOB
    • POST A JOB
  • EDGE ADVANTAGE
  • FACILITES
  • RESOURCES
    • PRODUCTS & SERVICES DIRECTORY
    • CALENDAR
    • CONTACT
    • ABOUT US
    • O&P LIBRARY
    • THE GUIDE
    • CUSTOM PUBLICATIONS
    • ADVERTISING
    • EDGE DIRECT
    • AMPLITUDE
  • OANDP-L
  • LOGIN

© 2021The O&P EDGE

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
The O&P EDGE Magazine
 
Required 'Candidate' login to applying this job. Click here to logout And try again
 

Login to your account

  • Forgot Password? | Sign Up

Reset Password

  • Already have an account? Login

Enter the username or e-mail you used in your profile. A password reset link will be sent to you by email.

Signup to your Account

  • By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

    Already have an account? Login

Close
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
 

Account Activation

Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder. Click here to resend the activation email. If you entered an incorrect email address, you will need to re-register with the correct email address.